![]() |
市場調查報告書
商品編碼
1347917
次世代定序服務市場:依類型、依技術、依應用、終端用戶 - 2030 年世界預測Next Generation Sequencing Services Market by Type (Targeted, RNA, De Novo, WES, WGS), Technology (Sequencing by Synthesis, Ion Semiconductor, SMRT, Nanopore), Application (Research, Clinical [Oncology, Reproductive]), End User - Global Forecast to 2030 |
下一代定序(NGS)服務市場按類型(靶向、RNA、De Novo、WES、WGS)按技術(合成定序、離子半導體、SMRT、奈米孔)按應用(研究、臨床[腫瘤學、生殖科學] )按最終由用戶 - 2030 年世界預測
下一代定序儀服務市場預計到2030年將達到203.9億美元,2023年至2030年複合年增長率為19.9%。基於徹底的二次和初步研究以及對市場情景的詳細分析,該報告討論了主要的市場驅動因素、限制因素、挑戰和機會。
該市場的成長主要是由NGS程序成本降低、新標靶療法的開發和批准、癌症患病率上升、NGS服務提供者與製藥公司之間的聯盟、測序基礎設施的高成本推動的,這是由於技術進步。此外,序列資料分析的進步以及 NGS 在癌症和農業基因組研究中應用的增加預計將為 NGS 服務提供者提供重大的成長機會。
然而,替代技術的可用性、缺乏熟練的樣本製備和分析專家以及精準醫學的實際變化可能會限制 NGS 服務市場的成長。此外,診斷測試的監管和標準化問題、倫理問題以及與非侵入性產前基因測試相關的成本是該市場成長的主要挑戰。
The Next Generation Sequencing (NGS) Services Market By Type (Targeted, RNA, De Novo, WES, WGS) Technology (Sequencing by Synthesis, Ion Semiconductor, SMRT, Nanopore) Application (Research, Clinical [Oncology, Reproductive]) End User-Global Forecast to 2030
The next generation sequencing services market is expected to grow at a CAGR of 19.9% from 2023 to 2030 to reach $20.39 billion by 2030. Following thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, and opportunities.
The growth of this market is mainly attributed to the reduced cost of NGS procedures, the development and approval of new targeted therapies, the rising prevalence of cancer, partnerships between NGS service providers and pharmaceutical companies, the high cost of sequencing infrastructure, and technological advancements in NGS. In addition, advancements in sequencing data analytics and the increasing applications of NGS in cancer and agri-genomics research are expected to offer significant growth opportunities for NGS service providers.
However, the availability of alternative technologies, lack of skilled professionals for sample preparation and analysis, and actionable mutations for precision medicine may restrain the growth of the NGS services market. Moreover, regulatory & standardization concerns in diagnostic testing and the ethical issues & costs related to non-invasive prenatal genetic testing are major challenges to the growth of this market.
Based on type, the global NGS services market is segmented into targeted sequencing services, whole-genome sequencing services, RNA sequencing services, exome sequencing services, de novo sequencing services, ChIP sequencing services, methyl sequencing services, and other NGS services. In 2023, the targeted sequencing services segment is estimated to account for the largest share of the global NGS services market. The large share of this segment can be attributed to the relatively lower cost, faster turnaround time, and accurate, easy-to-interpret results of targeted sequencing in the study of disease-related genes.
Based on technology, the global NGS services market is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and DNA nanoball sequencing. In 2023, the sequencing by synthesis segment is estimated to account for the largest share of the global NGS services market. The large share of this segment is attributed to its highest yield of error-free throughput, base call value above Q30, and higher accuracy in DNA sequencing compared to other sequencing technologies available in the market.
Based on application, the global NGS services market is segmented into research applications and clinical applications. In 2023, the research applications segment is estimated to account for the largest share of the global NGS services market. This segment's large share is mainly attributed to the increasing demand for gene-based medicines, growing investments in drug research and development activities, and increasing research programs for personalized medicine.
Based on end user, the global NGS services market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, academic institutes & research centers, and other end users. In 2023, the hospitals & clinics segment is estimated to account for the largest share of the global NGS services market. The largest share of this segment is attributed to factors such as high capital requirements for building in-house NGS capabilities in hospitals & clinics, the rising prevalence of cancer and other chronic diseases, the growing demand for advanced medical treatments, and the rising number of biomarker-based therapies.
An in-depth analysis of the geographical scenario of the next generation sequencing services market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to command the largest share of the global next generation sequencing services market in 2023, followed by Europe and Asia-Pacific.
Key companies operating in the global next generation sequencing services market are Illumina, Inc. (U.S.), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Eurofins Scientific S.E. (Luxembourg), Macrogen, Inc. (South Korea), LGC Limited (U.K.), GENEWIZ, Inc. (U.S.), Beijing Genomics Institute (China), MedGenome, Inc. (U.S.), DNA Link, Inc. (South Korea), Novogene Co., Ltd. (China), CD Genomics (U.S.), SeqLL, Inc. (U.S.), Otogenetics Corporation (U.S.), Foundation Medicine, Inc. (U.S.), Quest Diagnostics Incorporated (U.S.), and Invitae Corporation (U.S.).
Next Generation Sequencing Services Market Assessment-by Type
Next Generation Sequencing Services Market Assessment-Technology
Next generation Sequencing Services Market Assessment-Application
(Other research applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies, and other clinical applications include the detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food-borne illnesses)
Next Generation Sequencing Services Market Assessment-by End User
Next Generation Sequencing Services Market Assessment-by Geography